Stryker (Germany) Top Insiders
| SYK Stock | EUR 308.00 2.20 0.72% |
Stryker employs about 51 K people. The company is managed by 37 executives with a total tenure of roughly 365 years, averaging almost 9.0 years of service per executive, having 1378.38 employees per reported executive. Examination of Stryker's management performance can provide insight into the company performance.
| Kevin Lobo CEO President CEO, Director |
| William Parfet Chairman Non-Executive Independent Chairman of the Board |
Stryker |
Stryker Management Team Effectiveness
The company has return on total asset (ROA) of 0.0618 % which means that it generated a profit of $0.0618 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1498 %, meaning that it generated $0.1498 on every $100 dollars invested by stockholders. Stryker's management efficiency ratios could be used to measure how well Stryker manages its routine affairs as well as how well it operates its assets and liabilities.Stryker Workforce Comparison
Stryker is currently regarded as top stock in number of employees category among related companies. The total workforce of Medical Devices industry is at this time estimated at about 57,298. Stryker totals roughly 51,000 in number of employees claiming about 89% of all equities under Medical Devices industry.
The company has Profit Margin (PM) of 0.13 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.19 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.19. Stryker Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Stryker Price Series Summation is a cross summation of Stryker price series and its benchmark/peer.
Stryker Notable Stakeholders
A Stryker stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Stryker often face trade-offs trying to please all of them. Stryker's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Stryker's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Kevin Lobo | President CEO, Director | Profile | |
| William Parfet | Non-Executive Independent Chairman of the Board | Profile | |
| Fink | Vice President Global Human Resources | Profile | |
| William Berry | Principal Accounting Officer, Vice President Corporate Controller | Profile | |
| Katherine Owen | Vice President - Strategy and Investor Relations | Profile | |
| Graham Mclean | President Asia-Pacific | Profile | |
| David Floyd | Group President - Orthopaedics | Profile | |
| William Jellison | CFO, Vice President | Profile | |
| Yin Becker | Vice President of Communication and Public Affairs | Profile | |
| Timothy Scannell | Group President - MedSurg and Neurotechnology | Profile | |
| Robert Fletcher | Vice President Chief Legal Officer | Profile | |
| Dean Bergy | Vice President Corporate Secretary | Profile | |
| Glenn Boehnlein | CFO, Vice President | Profile | |
| Viju Menon | Group President - Global Quality and Business Operations | Profile | |
| Lonny Carpenter | Group President - Global Quality and Operations | Profile | |
| Bijoy Sagar | CIO, Vice President | Profile | |
| Bronwen Taylor | Vice President - Compliance and Risk Management | Profile | |
| Steven Benscoter | Vice President - Human Resources | Profile | |
| Kathryn Fink | Chief Human Resource Officer, Vice President | Profile | |
| Scott Bruder | Vice President Chief Medical and Scientific Officer | Profile | |
| Andrew Silvernail | Independent Director | Profile | |
| Sherilyn McCoy | Independent Director | Profile | |
| Ronda Stryker | Independent Director | Profile | |
| Allan Golston | Independent Director | Profile | |
| Louise Francesconi | Independent Director | Profile | |
| Roch Doliveux | Independent Director | Profile | |
| Rajeev Suri | Independent Director | Profile | |
| Mary Brainerd | Director | Profile | |
| Srikant Datar | Independent Director | Profile | |
| Howard Cox | Independent Director | Profile | |
| Robert Cohen | CTO Replacement | Profile | |
| Curtis Hall | Chief Legal Officer | Profile | |
| Spencer Stiles | Group Spine | Profile | |
| Andrew Pierce | Group Neurotechnology | Profile | |
| Jason Beach | VP Relations | Profile | |
| Alan Douville | Chief VP | Profile | |
| Michael Hutchinson | General Counsel | Profile |
About Stryker Management Performance
The success or failure of an entity such as Stryker often depends on how effective the management is. Stryker management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Stryker management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Stryker management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Stryker Corporation operates as a medical technology company. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan. STRYKER CORP operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 36000 people.
The data published in Stryker's official financial statements usually reflect Stryker's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Stryker. For example, before you start analyzing numbers published by Stryker accountants, it's critical to develop an understanding of what Stryker's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Stryker's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Stryker's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Stryker's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Stryker. Please utilize our Beneish M Score to check the likelihood of Stryker's management manipulating its earnings.
Stryker Workforce Analysis
Traditionally, organizations such as Stryker use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Stryker within its industry.Stryker Manpower Efficiency
Return on Stryker Manpower
| Revenue Per Employee | 361.7K | |
| Revenue Per Executive | 498.6M | |
| Net Income Per Employee | 46.2K | |
| Net Income Per Executive | 63.7M |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stryker. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Stryker Stock please use our How to Invest in Stryker guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for Stryker Stock analysis
When running Stryker's price analysis, check to measure Stryker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stryker is operating at the current time. Most of Stryker's value examination focuses on studying past and present price action to predict the probability of Stryker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stryker's price. Additionally, you may evaluate how the addition of Stryker to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |